spacer
 
|

Click below to register.

Friday, March 31, 2017
Marriott Marquis San Diego Marina

333 West Harbor Drive
San Diego, CA
Rooms: Grand Ballroom 3, 4, 6

6:00 PM – 6:30 PM: Registration & Dinner
6:30 PM – 7:30 PM: Interactive Symposium

Jointly provided by the Elsevier Office of Continuing Medical Education and ASiM.

This activity is supported by an independant educational grant from Allergan, Inc, and Ironwood Pharmaceuticals.


OVERVIEW
Inflammatory bowel syndrome (IBS) is the most common gastrointestinal disorder seen by primary care providers, yet it remains a source of frustration for both patients and physicians. Recent advances in our understanding of the etiology and pathophysiology of IBS have led to new diagnostic guidelines that avoid unnecessary testing so that IBS is no longer a diagnosis of exclusion. Treatment options are varied and evolving and include pharmacologic and non-pharmacologic options depending on the subtype of IBS and individual patient characteristics. This live symposium will provide participants with the opportunity to assess new data and remaining challenges in the diagnosis and treatment of patients with IBS via interactive case scenarios.

GOAL
The goal of this activity is to provide primary care physicians and other healthcare professionals with the most up-to-date clinical knowledge and strategies for the optimal diagnosis and treatment of patients with IBS.

EDUCATIONAL OBJECTIVES
Upon completion of this activity, participants will be better able to do the following:
  • EVALUATE updated IBS diagnostic guidelines, using them to make a positive symptom-based diagnosis.
  • COMPARE the efficacy and safety of newer treatment options for IBS-D and IBS-C.
  • RECOGNIZE patient and disease-specific factors that contribute to therapy decision-making in IBS management.
AGENDA
6:00 – 6:30 PM Registration and Dinner
6:30 – 6:40 PM Overview and Activity Goals
Gerald W. Smetana, MD, MACP
6:40 – 6:55 PM Case 1: The Diagnosis of IBS: Toward a Gold Standard?
Gerald W. Smetana, MD, MACP, and Ali Rezaie, MD, MSc, FRCP(C)
6:55 – 7:05 PM Case 2: Treatment Options for IBS-C
Gerald W. Smetana, MD, MACP, and Ali Rezaie, MD, MSc, FRCP(C)
7:05 – 7:20 PM Case 3: Treatment Options for IBS-D
Gerald W. Smetana, MD, MACP, and Ali Rezaie, MD, MSc, FRCP(C)
7:20 – 7:30 PM Question and Answer Session/Conclusions
Gerald W. Smetana, MD, MACP

This schedule is subject to change.

FACULTY
Anthony J. Lembo, MD (Chair)
Associate Professor of Medicine
Harvard Medical School Department of Medicine
Division of Gastroenterology
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Ali Rezaie, MD, MSc, FRCP(C)
Assistant Director
GI Motility Program
Assistant Professor of Medicine
Cedars-Sinai Medical Center
Los Angeles, California

Gerald W. Smetana, MD, MACP
Division of General Medicine and Primary Care
Beth Israel Deaconess Medical Center
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

TARGET AUDIENCE
This live symposium is intended for primary care providers. No prerequisites required.

CME CREDIT(Physicians)
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Elsevier Office of Continuing Medical Education and ASiM. The Elsevier Office of Continuing Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

The Elsevier Office of Continuing Medical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


DISCLOSURE OF CONFLICTS OF INTEREST
The Elsevier Office of Continuing Medical Education requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Elsevier Office of Continuing Medical Education policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Americans with Disabilities Act (ADA)
Event staff will be glad to assist you with any special needs (physical, dietary, etc). Please contact Adrienne Roser at ASiM prior to the live event at aroser@asimcme.com (908-253-9001 ext. 23).

Registration Instructions
Register by clicking arrow below or calling 908-253-9001 ext. 23.

Fee Information
There is no fee for this educational activity.

<img src="http://www.jhasio1.com/asim/pictures/proceed_pretestASIM.png" alt="procced to pretest" border="0" />


spacer  
  spacer
Advanced Studies in Medicine © 2014 Contact Us
spacer  
spacer